| Literature DB >> 30897155 |
Scott A Dee, Fernando V Bauermann, Megan C Niederwerder, Aaron Singrey, Travis Clement, Marcelo de Lima, Craig Long, Gilbert Patterson, Maureen A Sheahan, Ana M M Stoian, Vlad Petrovan, Cassandra K Jones, Jon De Jong, Ju Ji, Gordon D Spronk, Luke Minion, Jane Christopher-Hennings, Jeff J Zimmerman, Raymond R R Rowland, Eric Nelson, Paul Sundberg, Diego G Diel.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0194509.].Entities:
Year: 2019 PMID: 30897155 PMCID: PMC6428285 DOI: 10.1371/journal.pone.0214529
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
An overview of viability across all viruses tested in the study, including PEDV [14] highlighting half-life estimates (in days) of viruses presenting measurable endpoint titers across ingredients on Batch 4 samples.
| INGREDIENT | SVA | ASFV | PSV | PEDV | FCV | PCV2 | PRRSV | BHV-1 |
|---|---|---|---|---|---|---|---|---|
| 22.3 | 4.6 | 6.2 | 44.5 | • | 4.4 | |||
| • | 4.7 | 6.2 | • | • | • | • | ||
| 7.4 | 5.0 | 7.2 | • | • | • | 4.4 | ||
| 14.8 | • | • | • | • | • | |||
| 5.9 | • | • | 6.6 | • | • | |||
| • | 5.1 | • | • | • | • | |||
| 3.9 | • | 7.7 | • | • | • | |||
| 14.9 | 4.6 | 6.7 | • | • | • | • | ||
| 8.9 | 4.2 | 8.6 | • | • | • | • | ||
| 6.4 | 4.1 | 6.6 | • | • | • | • | ||
| 12.7 | 4.4 | 5.1 | 7.9 | • | • | • | ||
| 8.9 | 4.3 | 6.2 | 4.3 | • | • | |||
| • | • | • | • | • | • | • | • | |
| • | 4.7 | • | • | • | • | • | • |
Note: All ingredients tested for IAV-S, BVDV, CDV, VSV were negative by both VI and bioassay.
* = Endpoint titer T ½estimate (in days) expressed in units of TCID50
• = Negative by both VI and bioassay
+ = Negative by VI and positive by bioassay
Light grey shading = While viable PEDV was recovered from these samples, viral titers were expressed in units of FFU, not TCID50 Dark grey shading = Feed ingredients not included in this study